Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Stockholder's Equity Statement

v3.20.1
Consolidated Statement of Stockholder's Equity Statement - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Accumulated Deficit [Member]
Shares issued, beginning of period (in shares) at Dec. 31, 2018   69,551      
Total stockholders' equity, beginning of period at Dec. 31, 2018 $ 399,936 $ 7 $ 493,287 $ 272 $ (93,630)
Common Stock Issued Pursuant To Equity Awards Net Shares   981      
Common stock issued pursuant to equity awards, net, value 5,615   5,615    
APIC, Share-based Payment Arrangement, Increase for Cost Recognition 7,747   7,747    
Cumulative Effect on Retained Earnings, Net of Tax (268)       (268)
Other Comprehensive Income (Loss), Net of Tax 25     25  
Net income (loss) (4,851)       (4,851)
Total stockholders' equity, end of period at Mar. 31, 2019 408,204 $ 7 506,649 297 (98,749)
Shares issued, end of period (in shares) at Mar. 31, 2019   70,532      
Shares issued, beginning of period (in shares) at Dec. 31, 2019   71,931      
Total stockholders' equity, beginning of period at Dec. 31, 2019 414,920 $ 7 529,596 (887) (113,796)
Common Stock Issued Pursuant To Equity Awards Net Shares   414      
Common stock issued pursuant to equity awards, net, value 2,612   2,612    
APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6,827   6,827    
Other Comprehensive Income (Loss), Net of Tax (733)     (733)  
Net income (loss) (15,469)       (15,469)
Total stockholders' equity, end of period at Mar. 31, 2020 $ 408,157 $ 7 $ 539,035 $ (1,620) $ (129,265)
Shares issued, end of period (in shares) at Mar. 31, 2020   72,345